Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...

Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...

AI and ML predict solubilization technologies, optimizing drug-excipient interactions and reducing trial-and-error in formulation development. Digital twins, trained ...

Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded ...

Objective The objective of this study is to assess the association between childhood exposure to pets and farm animals and ...

The Ascendancy Of Artificial Intelligence In Quality Assurance It feels like everywhere you look these days, AI ...

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...

The FDA has cleared the first artificial intelligence (AI) drug development tool to help evaluate fatty liver disease in ...

Sanjay Konagurthu of Thermo Fisher Scientific discusses how AI and ML can help solve the dilemma of poor solubility. In the above interview—the first in a two-part installment—Dr. Konagurthu discusses ...

The American Cancer Society has recently updated cervical screening guidelines for HPV and cervical cancer. Here are the main ...